Fig. 4From: Development of a necroptosis-related gene signature and the immune landscape in ovarian cancerSurvival analyses in subgroups (A) age < 60, (B) age ≧ 60, (C) grade 3, and (D) stage III-IV. (E) PCA of the high- and low-risk groups stratified by the whole-genome (F), NRGs (G), and the NRG signatureBack to article page